Neoadjuvant Chemotherapy versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study.
Toshitaka SugawaraSalvador Rodriguez FrancoSamantha ShermanRobert J TorphyKathryn ColbornOskar FranklinJun IshidaSamuele GrandiMohammed H Al-MusawiAna GleisnerRichard D SchulickMarco Del ChiaroPublished in: Annals of surgery (2023)
The findings suggest that multiagent NAC followed by resection is associated with improved survival compared to upfront surgery.